New Findings Show Sustained Seizure Reduction

with the RNS® System

Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the first and only medical device that can monitor and respond to brain activity. It is a treatment for drug-resistant epilepsy for individuals 18 and older who have focal seizures that start in one or two locations in the brain. Recently published studies have shown a 50-70% median seizure reduction at 6 years, and over a quarter of study patients reported periods of seizure freedom lasting 6 months or more1, 2.

Epilepsy and the RNS System Infographics

Click an infographic to view larger image, download, and share.

Drug-Resistant Epilepsy Facts

Treatment Options for Drug-Resistant Epilepsy
Treatment Options for Drug-Resistant Epilepsy

The RNS System has been featured in…

The NeuroPace RNS System has been featured in a variety of news media. The views expressed in the news stories below are the views of the media, and not NeuroPace. The patient testimonials in these stories reflect the personal experiences of individual(s). Individual results will vary. Refer to labeling for a description of the RNS® System, important prescribing information, indications for use, and safety information.

Supporting articles for healthcare professionals

Recent scientific publications and coverage on the long-term outcomes in mesial temporal and neocortical patients.

Geller EB, et al., 2017. Brain responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.

Read more

Jobst BC, et al., 2017. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas.

Read more

An interview with Barbara Jobst, MD, PhD. “When Drugs and Surgery Don’t Work, an Option in Epilepsy”.

Read more

1Geller et al., Epilepsia, 2017; 2Jobst et al., Epilepsia, 2017